Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Nov 2011 - :1432-0851 [PMID:22086161] [Palma M] [Hansson L] [Choudhury A] [Näsman-Glaser B] [Eriksson I] [Adamson L] [Rossmann E] [Widén K] [Horváth R] [Kokhaei P] [Vertuani S] [Mellstedt H] [Osterborg A]
Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells. Apr 2011 - Immunotherapy; 3(4):1750-7448 [PMID:21463196] [Westers TM] [van den Ancker W] [Bontkes HJ] [Janssen JJ] [van de Loosdrecht AA] [Ossenkoppele GJ]
Vaccine therapy and chronic lymphocytic leukaemia. Oct 2008 - Best Pract Res Clin Haematol; 21(3):1521-6926 [PMID:18790447] [Ramsay AG] [Gribben JG]
Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia. Sep 2008 - Cancer Immunol. Immunother.; 57(11):0340-7004 [PMID:18663443] [Palma M] [Adamson L] [Hansson L] [Kokhaei P] [Rezvany R] [Mellstedt H] [Osterborg A] [Choudhury A]
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia. Aug 2008 - J. Leukoc. Biol.; 84(1):0741-5400 [PMID:18426971] [Lee JJ] [Foon KA] [Mailliard RB] [Muthuswamy R] [Kalinski P]
Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies. Jul 2008 - Physiol Res; 57(2):0862-8408 [PMID:17552881] [Pytlík R] [Hofman P] [Kideryová L] [Cervinková P] [Obrtlíková P] [Sálková J] [Trnený M] [Klener P]
Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response. Jun 2008 - Leukemia; 22(5):1476-5551 [PMID:18323802] [Hus I] [Schmitt M] [Tabarkiewicz J] [Radej S] [Wojas K] [Bojarska-Junak A] [Schmitt A] [Giannopoulos K] [Dmoszyńska A] [Roliński J]
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia. May 2007 - Br. J. Haematol.; 137(4):0007-1048 [PMID:17408402] [Westermann J] [Kopp J] [van Lessen A] [Hecker AC] [Baskaynak G] [le Coutre P] [Döhner K] [Döhner H] [Dörken B] [Pezzutto A]
Dendritic cell vaccines for leukemia patients. Apr 2007 - Expert Rev Anticancer Ther; 7(3):1744-8328 [PMID:17338648] [Schmitt A] [Hus I] [Schmitt M]
Current status of immunotherapy in B cell malignancies. Nov 2006 - Curr Drug Targets; 7(10):1873-5592 [PMID:17073599] [Kofler DM] [Mayr C] [Wendtner CM]
Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation. Jul 2006 - Leuk. Res.; 30(7):0145-2126 [PMID:16527350] [Orsini E] [Calabrese E] [Maggio R] [Pasquale A] [Nanni M] [Trasarti S] [Tafuri A] [Guarini A] [Foa R]
Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies. Jun 2006 - Leuk. Lymphoma; 47(4):1042-8194 [PMID:16690526] [Ritchie D] [Hermans I] [Yang J] [Walton J] [Matthews K] [Carter J] [Findlay M] [Dady P] [Rawson P] [Ronchese F]
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation. May 2006 - J. Leukoc. Biol.; 79(4):0741-5400 [PMID:16461746] [Boissel N] [Rousselot P] [Raffoux E] [Cayuela JM] [Soulier J] [Mooney N] [Charron D] [Dombret H] [Toubert A] [Rea D]
Vaccine strategies to treat lymphoproliferative disorders. Jan 2006 - Pathology; 37(6):0031-3025 [PMID:16373232] [Radford KJ] [Vari F] [Hart DN]
Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate. Jan 2006 - Leuk. Lymphoma; 47(2):1042-8194 [PMID:16321861] [Suresh K] [Fraser G] [Scheid E] [Leber B] [Gauldie J] [Foley R]
